Dorothea Siegel-Axel
Corporate Officer/Principal bei Eberhard Karls Universität Tübingen
Profil
Dorothea Siegel-Axel is the founder of Corimmun GmbH founded in 2006 and advanceCOR GmbH founded in 2012.
She is currently the Head-Cardiology Department at Eberhard Karls Universität Tübingen.
Aktive Positionen von Dorothea Siegel-Axel
| Unternehmen | Position | Beginn |
|---|---|---|
| Eberhard Karls Universität Tübingen | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Dorothea Siegel-Axel
| Unternehmen | Position | Ende |
|---|---|---|
advanceCOR GmbH
 advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Gründer | - |
Corimmun GmbH
 Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Corimmun GmbH
Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Health Technology |
advanceCOR GmbH
advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Health Technology |
